Y-mAbs Therapeutics (YMAB) PT Raised to $41 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst Robert Burns raised the price target on Y-mAbs Therapeutics (NASDAQ: YMAB) to $41.00 (from $40.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
